Insider · CIK 0001263230
Robert J Perez
Files at RAPP (Rapport Therapeutics, Inc.). First filing -, latest -.
In brief
Robert J Perez files SEC Form 4 as director at RAPP (Rapport Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert J Perez has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 7, 2024 | VIR Vir Biotechnology, Inc. | 42,377 0.03% of outstanding | $474k | Jun 7, 2024 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | RAPP Rapport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,200 | $0.00 | $0 | 15,200 | Jun 10, 2026 |
| Jun 17, 2025 | RAPP Rapport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,925 | $0.00 | $0 | 10,925 | Jun 18, 2025 |
| Nov 7, 2024 | RAPP Rapport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +29,756 | $0.00 | $0 | 29,756 | Nov 7, 2024 |
Questions about Robert J Perez
Answered from the filings on this page, as of the latest one.
Is Robert J Perez buying or selling?
Robert J Perez has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert J Perez's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert J Perez has 0.
Where does Robert J Perez file Form 4?
Robert J Perez has filed Form 4 at RAPP (Rapport Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.